3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
9
Agnosia
6
Urinary Bladder Neoplasms
4
Pain, Postoperative
4
Neoplasms
4
Pancreatic Neoplasms
3
Neoplastic Cells, Circulating
2
Lung Neoplasms
2
Liver Neoplasms
2
Leiomyoma
2
Colorectal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Anesthesia
2
Acute Pain
2
Uterine Neoplasms
1
Uterine Hemorrhage
1
Uterine Diseases
1
Uterine Cervical Neoplasms
1
Respiratory Aspiration
1
Recurrence
1
Pulmonary Atelectasis
1
Prostatic Neoplasms
1
Postoperative Nausea and Vomiting
1
Postoperative Complications
1
Pneumothorax
1
Pleural Neoplasms
1
Pleural Effusion, Malignant
1
Pleural Diseases
1
Pericardial Effusion
1
Pancreatic Adenocarcinoma
1
Interventions
Tamoxifen
4
Exercise
3
pyrotinib
2
abemaciclib
2
Paclitaxel
2
Metformin
2
Letrozole
2
Cyclophosphamide
2
Control Groups
2
Capecitabine
2
Bupivacaine
2
Aromatase Inhibitors
2
pembrolizumab
1
pegylated granulocyte colony-stimulating factor
1
pegfilgrastim
1
palbociclib
1
iniparib
1
exemestane
1
durvalumab
1
darolutamide
1
Yoga
1
Waiting Lists
1
Vitamin D
1
Tretinoin
1
Trastuzumab
1
Tocopherols
1
Thioctic Acid
1
Standard of Care
1
Sodium Chloride
1
Self-Help Groups
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Breast Cancer Female
×
Anesthesia, General
×
Clear all
NCT03779685
2020-08-05
GENEXAN
Azienda Ospedaliera San Gerardo di Monza
Phase NA
Unknown
100 enrolled